Matthew Smyth, MD

Icahn School of Medicine at Mount Sinai, Canada

Poster(s):

• P2561 - Risankizumab Sustains Remission and Improves Anti-TNF-Induced Psoriasiform Dermatitis in Well Controlled Crohn's Disease Patients Switched from Anti-TNF Therapy
  Monday, October 28, 2024

  10:30 AM – 4:00 PM ET

• P2562 - Early Sonographic Transmural Remission as a Post-Induction Target Across Advanced Therapies in Crohn’s Disease
  Monday, October 28, 2024

  10:30 AM – 4:00 PM ET